192 related articles for article (PubMed ID: 2642224)
1. [Membrane characteristics of pathological clones of B-lymphocytes in patients with chronic lymphocytes leukemia (CLL)].
Pluta A
Pol Arch Med Wewn; 1989; 82(4-6):195-201. PubMed ID: 2642224
[No Abstract] [Full Text] [Related]
2. [Immunologic phenotype of lymphocytes in chronic B-cell lymphocytic leukemia. I. B- and T-lymphocytes in chronic lymphocytic leukemia].
Rupniewska ZM; Wach M; Kowal M; Roliński J; Antosz H
Acta Haematol Pol; 1992; 23(1):21-7. PubMed ID: 1615748
[TBL] [Abstract][Full Text] [Related]
3. [Cell membrane characteristics of B-lymphocytes in chronic lymphocytic leukemia. II. Expression of B-cell markers].
Pluta A; Górski A; Nowaczyk M
Pol Arch Med Wewn; 1991 Sep; 86(3):154-8. PubMed ID: 1725559
[TBL] [Abstract][Full Text] [Related]
4. Phenotypic heterogeneity of B- and T-cell differentiation antigens in B-CLL.
Merle-Beral H; Blanc C; Chastang C; Debre P
Eur J Haematol; 1988 Sep; 41(3):197-203. PubMed ID: 3263283
[TBL] [Abstract][Full Text] [Related]
5. [The role of HLA antigens class II in differentiation of normal and pathological B-lymphocytes. II. HLA-D expression in leukemia and non-Hodgkin's lymphoma].
Pluta A
Acta Haematol Pol; 1990; 21(1):118-23. PubMed ID: 2260404
[No Abstract] [Full Text] [Related]
6. Normal B cell compartment in chronic lymphatic leukemia.
Pluta A; Górski A; Nowaczyk M; Modlińska M
Hematol Oncol; 1990; 8(3):121-4. PubMed ID: 1695606
[TBL] [Abstract][Full Text] [Related]
7. [The role of HLA antigens class II in differentiation of normal and pathological B-lymphocytes. I. Normal hematopoiesis].
Pluta A
Acta Haematol Pol; 1990; 21(1):113-7. PubMed ID: 2260403
[No Abstract] [Full Text] [Related]
8. Reduced expression of CD20 antigen as a characteristic marker for chronic lymphocytic leukemia.
Almasri NM; Duque RE; Iturraspe J; Everett E; Braylan RC
Am J Hematol; 1992 Aug; 40(4):259-63. PubMed ID: 1380203
[TBL] [Abstract][Full Text] [Related]
9. [Characteristics of cell membrane of B-lymphocytes in chronic lymphocytic leukemia. I. Expression of class II antigens (HLA-D)].
Pluta A; Górski A; Nowaczyk M
Pol Arch Med Wewn; 1991 Sep; 86(3):149-53. PubMed ID: 1725558
[TBL] [Abstract][Full Text] [Related]
10. Distribution and function of lymphocyte surface antigens. Molecules costimulating T lymphocyte activation and effector function.
Lanier LL
Ann N Y Acad Sci; 1993 Mar; 677():86-93. PubMed ID: 8494250
[No Abstract] [Full Text] [Related]
11. DRC1 expression on normal and pathological lymphoid cells.
Antoine N; Heinen E; Marcoty C; Bosseloir A; Simar L
Adv Exp Med Biol; 1993; 329():449-53. PubMed ID: 7691033
[No Abstract] [Full Text] [Related]
12. Human leukocyte antigen-DO regulates surface presentation of human leukocyte antigen class II-restricted antigens on B cell malignancies.
Kremer AN; van der Meijden ED; Honders MW; Pont MJ; Goeman JJ; Falkenburg JH; Griffioen M
Biol Blood Marrow Transplant; 2014 May; 20(5):742-7. PubMed ID: 24530695
[TBL] [Abstract][Full Text] [Related]
13. B-cell chronic lymphocytic leukemia cells express a surface membrane phenotype of activated, antigen-experienced B lymphocytes.
Damle RN; Ghiotto F; Valetto A; Albesiano E; Fais F; Yan XJ; Sison CP; Allen SL; Kolitz J; Schulman P; Vinciguerra VP; Budde P; Frey J; Rai KR; Ferrarini M; Chiorazzi N
Blood; 2002 Jun; 99(11):4087-93. PubMed ID: 12010811
[TBL] [Abstract][Full Text] [Related]
14. Clonal cell surface structures related to differentiation, activation and homing in B-cell chronic lymphocytic leukemia and monoclonal lymphocytosis of undetermined significance.
Kimby E; Mellstedt H; Björkholm M; Holm G
Eur J Haematol; 1989 Nov; 43(5):452-9. PubMed ID: 2612619
[TBL] [Abstract][Full Text] [Related]
15. Dual role of the CXCL12 polymorphism in patients with chronic lymphocytic leukemia.
Butrym A; Gebura K; Iwaszko M; Kuliczkowski K; Bogunia-Kubik K; Mazur G
HLA; 2016 Jun; 87(6):432-8. PubMed ID: 27173875
[TBL] [Abstract][Full Text] [Related]
16. In vitro activation of leukaemic B cells by interleukin-4 and antibodies to CD40.
Crawford DH; Catovsky D
Immunology; 1993 Sep; 80(1):40-4. PubMed ID: 7503945
[TBL] [Abstract][Full Text] [Related]
17. [Significance of immunophenotyping of blood and cerebrospinal fluid lymphocytes for the diagnosis of leukemic meningosis in a patient with chronic lymphatic leukemia of the B-cell type].
Ottinger H; Petrasch S; Püllen R; Brittinger G
Med Klin (Munich); 1990 Mar; 85 Suppl 1():141-3. PubMed ID: 1692953
[No Abstract] [Full Text] [Related]
18. CD1 expression in B-CLL cells.
Merle-Béral H; Boumsell L; Michel A; Blanc C; Debré P
Nouv Rev Fr Hematol (1978); 1988; 30(5-6):327-30. PubMed ID: 3265504
[TBL] [Abstract][Full Text] [Related]
19. Association of bone marrow growth pattern, coexpression of CD14, and B-cell CD5 antigen density in 45 B-chronic lymphocytic leukemia (B-CLL) patients.
Paglieroni T; Caggiano V; MacKenzie MR
Ann N Y Acad Sci; 1992 May; 651():484-5. PubMed ID: 1376066
[No Abstract] [Full Text] [Related]
20. The immunological profile of B-cell disorders and proposal of a scoring system for the diagnosis of CLL.
Matutes E; Owusu-Ankomah K; Morilla R; Garcia Marco J; Houlihan A; Que TH; Catovsky D
Leukemia; 1994 Oct; 8(10):1640-5. PubMed ID: 7523797
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
